
- Founded
- 2015
- Employees
- 28
About Shasqi
Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two 'click', a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds.
Leadership at Shasqi
The team at the top of the org chart.
José M. Mejía Oneto
Founder and CEO
15 reports
Steve Abella
Chief Medical Officer
11 reports
Lindsay Daum
Executive Assistant To Chief Executive Officer
Sadie Whittaker, Ph.D.
Head of Communications
Jesse McFarland
Associate Director
Board
Lawrence D. Mayer
Advisor
Ronald W. Barrett
Advisor
Nina Shapiro
Advisor
William J. Rieflin
Advisor
Max Royzen
Advisor
Juan Jaen
Director